Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis.
Palmerini E, Sanfilippo R, Grignani G, Buonadonna A, Romanini A, Badalamenti G, Ferraresi V, Vincenzi B, Comandone A, Pizzolorusso A, Brunello A, Gelsomino F, De Pas T, Ibrahim T, Gurrieri L, Grosso F, Zanelli F, Pantaleo MA, Milesi L, Ciuffreda L, Ferrari V, Marchesi E, Quattrini I, Righi A, Setola E, Carretta E, Casali PG, Picci P, Ferrari S. Palmerini E, et al. Among authors: setola e. Front Oncol. 2022 Dec 8;12:1042479. doi: 10.3389/fonc.2022.1042479. eCollection 2022. Front Oncol. 2022. PMID: 36568164 Free PMC article.
Neoadjuvant chemotherapy for osteosarcoma of the extremity: intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome.
Bacci G, Forni C, Ferrari S, Longhi A, Bertoni F, Mercuri M, Donati D, Capanna R, Bernini G, Briccoli A, Setola E, Versari M. Bacci G, et al. Among authors: setola e. J Pediatr Hematol Oncol. 2003 Nov;25(11):845-53. doi: 10.1097/00043426-200311000-00006. J Pediatr Hematol Oncol. 2003. PMID: 14608193
Eribulin in advanced liposarcoma and leiomyosarcoma.
Setola E, Noujaim J, Benson C, Chawla S, Palmerini E, Jones RL. Setola E, et al. Expert Rev Anticancer Ther. 2017 Aug;17(8):717-723. doi: 10.1080/14737140.2017.1344098. Epub 2017 Jun 28. Expert Rev Anticancer Ther. 2017. PMID: 28621163 Review.
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients.
Palmerini E, Jones RL, Setola E, Picci P, Marchesi E, Luksch R, Grignani G, Cesari M, Longhi A, Abate ME, Paioli A, Szucs Z, D'ambrosio L, Scotlandi K, Fagioli F, Asaftei S, Ferrari S. Palmerini E, et al. Among authors: setola e. Acta Oncol. 2018 Jul;57(7):958-964. doi: 10.1080/0284186X.2018.1449250. Epub 2018 Mar 13. Acta Oncol. 2018. PMID: 29533113 Free article.
Pazopanib in relapsed osteosarcoma patients: report on 15 cases.
Longhi A, Paioli A, Palmerini E, Cesari M, Abate ME, Setola E, Spinnato P, Donati D, Hompland I, Boye K. Longhi A, et al. Among authors: setola e. Acta Oncol. 2019 Jan;58(1):124-128. doi: 10.1080/0284186X.2018.1503714. Epub 2018 Sep 12. Acta Oncol. 2019. PMID: 30207179 No abstract available.
Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?
Palmerini E, Torricelli E, Cascinu S, Pierini M, De Paolis M, Donati D, Cesari M, Longhi A, Abate M, Paioli A, Setola E, Ferrari S. Palmerini E, et al. Among authors: setola e. Pediatr Blood Cancer. 2019 Aug;66(8):e27792. doi: 10.1002/pbc.27792. Epub 2019 May 6. Pediatr Blood Cancer. 2019. PMID: 31058424
How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
Bongers MER, Karhade AV, Setola E, Gambarotti M, Groot OQ, Erdoğan KE, Picci P, Donati DM, Schwab JH, Palmerini E. Bongers MER, et al. Among authors: setola e. Clin Orthop Relat Res. 2020 Oct;478(10):2300-2308. doi: 10.1097/CORR.0000000000001305. Clin Orthop Relat Res. 2020. PMID: 32433107 Free PMC article.
80 results